Fingerprint
Dive into the research topics of 'A phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity
Alex A. Adjei, Charles Erlichman, Jenny N. Davis, David L. Cutler, Jeff A. Sloan, Randolph S. Marks, Lorelei J. Hanson, Phyllis A. Svingen, Pamela Atherton, W. Robert Bishop, Paul Kirschmeier, Scott H. Kaufmann
Research output: Contribution to journal › Article › peer-review
250
Scopus
citations